Atlantic Union Bankshares Corp Lowers Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Atlantic Union Bankshares Corp lessened its holdings in Zoetis Inc. (NYSE:ZTS) by 0.9% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 7,696 shares of the company’s stock after selling 70 shares during the period. Atlantic Union Bankshares Corp’s holdings in Zoetis were worth $1,504,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. William Allan Corp grew its position in shares of Zoetis by 100.3% during the third quarter. William Allan Corp now owns 28,892 shares of the company’s stock worth $5,645,000 after purchasing an additional 14,468 shares in the last quarter. Rockefeller Capital Management L.P. grew its holdings in Zoetis by 2.8% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 459,729 shares of the company’s stock valued at $89,785,000 after buying an additional 12,358 shares in the last quarter. Isthmus Partners LLC raised its position in shares of Zoetis by 1.1% during the third quarter. Isthmus Partners LLC now owns 68,648 shares of the company’s stock valued at $13,412,000 after buying an additional 760 shares during the last quarter. Hantz Financial Services Inc. lifted its holdings in shares of Zoetis by 4.4% in the third quarter. Hantz Financial Services Inc. now owns 141,299 shares of the company’s stock worth $27,607,000 after buying an additional 5,938 shares in the last quarter. Finally, Vinva Investment Management Ltd boosted its position in shares of Zoetis by 8.2% during the third quarter. Vinva Investment Management Ltd now owns 19,456 shares of the company’s stock worth $3,790,000 after acquiring an additional 1,467 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on ZTS shares. Argus upgraded shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler lifted their target price on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. Stifel Nicolaus increased their price target on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. BTIG Research lifted their price objective on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Finally, JPMorgan Chase & Co. increased their target price on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Zoetis presently has a consensus rating of “Buy” and a consensus price target of $221.44.

Zoetis Price Performance

Zoetis stock opened at $175.25 on Friday. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. The firm has a 50-day moving average price of $183.83 and a 200-day moving average price of $180.84. The firm has a market capitalization of $79.07 billion, a PE ratio of 32.94, a price-to-earnings-growth ratio of 2.71 and a beta of 0.90.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.12. The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.36 earnings per share. As a group, equities research analysts forecast that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be paid a $0.432 dividend. The ex-dividend date is Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a yield of 0.99%. Zoetis’s payout ratio is 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.